Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LFCR | US
0.04
0.77%
Healthcare
Drug Manufacturers-Specialty & Generic
31/08/2024
21/10/2024
5.25
5.27
5.27
5.17
Lifecore Biomedical Inc. together with its subsidiaries operates as an integrated contract development and manufacturing organization in the United States and internationally. The company operates through Lifecore Curation Foods and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services including technology development material component changes analytical method development formulation development pilot studies stability studies process validation and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic orthopedic and other markets. The Curation Foods segment engages in processing marketing and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical Inc. in November 2022. Lifecore Biomedical Inc. was incorporated in 1986 and is based in Chaska Minnesota.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
72.3%1 month
67.2%3 months
99.4%6 months
81.5%40.08
8.67
15.35
-32.48
0.52
9.51
2.52
3.51
-674.00K
193.34M
193.34M
-
-36.77
-
0.70
17.29
11.12
16.67
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.12
Range1M
1.12
Range3M
2.85
Rel. volume
1.21
Price X volume
863.67K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 11.09 | 198.44M | -3.40% | n/a | 0.60% |
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.63 | 163.79M | -1.50% | n/a | -113.78% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 1.91 | 152.06M | -0.52% | n/a | 1.07% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.8715 | 127.57M | 3.20% | n/a | 36.36% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.1244 | 124.14M | 0.89% | n/a | 1.10% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.49 | 122.78M | 2.76% | n/a | 8.14% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 0.78 | 117.61M | -2.50% | n/a | -294.40% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.15 | 109.64M | -0.86% | n/a | 30.76% |
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 3.63 | 109.53M | 0.55% | n/a | 0.00% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.8544 | 106.53M | -1.80% | n/a | -148.05% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.55 | 145.88M | -0.79% | n/a | 58.43% |
Unifi Inc | UFI | Textile Manufacturing | 6.87 | 125.41M | -3.10% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 32.87 | 94.40M | 1.83% | 5.16 | 19.82% |
Culp Inc | CULP | Textile Manufacturing | 5.71 | 71.32M | -3.55% | n/a | 11.29% |
ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.95 | 14.61M | 9.45% | n/a | 422.08% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 9.51 | - | Cheaper |
Ent. to Revenue | 2.52 | - | Cheaper |
PE Ratio | 40.08 | 30.05 | Expensive |
Price to Book | 15.35 | 13.15 | Par |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 99.42 | - | Riskier |
Debt to Equity | -32.48 | -1.88 | Cheaper |
Debt to Assets | 0.52 | 0.48 | Par |
Market Cap | 193.34M | - | Emerging |